Cargando…

Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison

Many dermatological conditions, such as eczema and psoriasis, are treated with topical therapeutic products. Instead of applying the active drug directly onto the skin, it is combined with a vehicle to aid in its delivery across the stratum corneum (SC) and into deeper regions of the skin, namely th...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Tanya M., Mijaljica, Dalibor, Townley, Joshua P., Spada, Fabrizio, Harrison, Ian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703425/
https://www.ncbi.nlm.nih.gov/pubmed/34959294
http://dx.doi.org/10.3390/pharmaceutics13122012
_version_ 1784621460463026176
author Barnes, Tanya M.
Mijaljica, Dalibor
Townley, Joshua P.
Spada, Fabrizio
Harrison, Ian P.
author_facet Barnes, Tanya M.
Mijaljica, Dalibor
Townley, Joshua P.
Spada, Fabrizio
Harrison, Ian P.
author_sort Barnes, Tanya M.
collection PubMed
description Many dermatological conditions, such as eczema and psoriasis, are treated with topical therapeutic products. Instead of applying the active drug directly onto the skin, it is combined with a vehicle to aid in its delivery across the stratum corneum (SC) and into deeper regions of the skin, namely the epidermis and dermis. Absorption into the systemic circulation is minimized. Topical vehicles are also used as cosmetic moisturizers (often termed emollient therapy) to ameliorate dry skin, which is a cornerstone of the management of various dermatological conditions, including xerosis, eczema, psoriasis, and aging. The most common topical vehicles include ointments, creams, gels, and lotions, among others. It is crucial that topical vehicles are chosen based upon the size and properties (wet/dry, mucous/non-mucous, healthy/diseased) of the skin to be treated in order to optimize application and contact of the product with the skin, as this can have profound impacts on potency, efficacy, and patient compliance. This review examines common topical vehicles used for drug delivery and cosmetic moisturizers, including their formulation, advantages and disadvantages, and effects on the skin. The unique rules imposed by governing regulatory bodies in Australia and around the world, in terms of topical product claims, are also briefly examined.
format Online
Article
Text
id pubmed-8703425
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87034252021-12-25 Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison Barnes, Tanya M. Mijaljica, Dalibor Townley, Joshua P. Spada, Fabrizio Harrison, Ian P. Pharmaceutics Review Many dermatological conditions, such as eczema and psoriasis, are treated with topical therapeutic products. Instead of applying the active drug directly onto the skin, it is combined with a vehicle to aid in its delivery across the stratum corneum (SC) and into deeper regions of the skin, namely the epidermis and dermis. Absorption into the systemic circulation is minimized. Topical vehicles are also used as cosmetic moisturizers (often termed emollient therapy) to ameliorate dry skin, which is a cornerstone of the management of various dermatological conditions, including xerosis, eczema, psoriasis, and aging. The most common topical vehicles include ointments, creams, gels, and lotions, among others. It is crucial that topical vehicles are chosen based upon the size and properties (wet/dry, mucous/non-mucous, healthy/diseased) of the skin to be treated in order to optimize application and contact of the product with the skin, as this can have profound impacts on potency, efficacy, and patient compliance. This review examines common topical vehicles used for drug delivery and cosmetic moisturizers, including their formulation, advantages and disadvantages, and effects on the skin. The unique rules imposed by governing regulatory bodies in Australia and around the world, in terms of topical product claims, are also briefly examined. MDPI 2021-11-26 /pmc/articles/PMC8703425/ /pubmed/34959294 http://dx.doi.org/10.3390/pharmaceutics13122012 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Barnes, Tanya M.
Mijaljica, Dalibor
Townley, Joshua P.
Spada, Fabrizio
Harrison, Ian P.
Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title_full Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title_fullStr Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title_full_unstemmed Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title_short Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
title_sort vehicles for drug delivery and cosmetic moisturizers: review and comparison
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703425/
https://www.ncbi.nlm.nih.gov/pubmed/34959294
http://dx.doi.org/10.3390/pharmaceutics13122012
work_keys_str_mv AT barnestanyam vehiclesfordrugdeliveryandcosmeticmoisturizersreviewandcomparison
AT mijaljicadalibor vehiclesfordrugdeliveryandcosmeticmoisturizersreviewandcomparison
AT townleyjoshuap vehiclesfordrugdeliveryandcosmeticmoisturizersreviewandcomparison
AT spadafabrizio vehiclesfordrugdeliveryandcosmeticmoisturizersreviewandcomparison
AT harrisonianp vehiclesfordrugdeliveryandcosmeticmoisturizersreviewandcomparison